BOISE, Idaho, June 11, 2020 /PRNewswire/ -- Ocular Innovations CEO, Michael Boerner, announced AutoLobby™; a new innovative "text to the car" service to help Ophthalmologists and Optometrists re-launch their practices as they open with COVID-19 patient workflow protocols.
AutoLobby™ is an SMS texting system that, for $59.00 per month, gives a practice the ability to manage patient staging in the parking lot, convey relevant information including brief videos to the patient, and send a text message when it's time to enter the building.
"COVID-19 and the subsequent 'shelter in place' requirements had a detrimental impact on our practice. We're excited about Ocular Innovations and its new product, AutoLobby™, helping us open our doors, re-start patient appointment and communication momentum, and put us on a path to good financial health," said Dr. Jerry Sude, President, Novus Clinic Total Eye Care in Akron, OH.
Ocular Innovations, based in Boise, Idaho provides innovative mobile-video engagement technologies without the use of Apps, passwords, and email addresses. Its services include VideoText™, Simple 5 Star™ Google Reviews, and new AutoLobby™ platform.
"At Ocular Innovations, we recognize that COVID-19 and statewide stay at home orders have materially impacted practices and staff teams. As doors reopen to treat patients, we are doing everything possible to help practices manage the new workflows that now include the 'blacktop waiting room' required by State social distancing guidelines. We are excited to help practices return to financial health and delivering great patient experiences," said Michael Boerner, Founder and CEO.
About Ocular Innovations, Inc.
To learn more, visit: www.ocularinnovationsinc.com
Tel: (208) 602-9090
View original content to download multimedia:http://www.prnewswire.com/news-releases/ocular-innovations-launches-autolobby-to-help-optometrists-and-ophthalmologists-rebuild-the-foundations-of-their-practices-optimize-patient-appointment-arrivals-to-adhere-to-covid-19-social-distancing-guidelines-and-increase-pr-301074746.html
SOURCE Ocular Innovations, Inc.